Lineweaver Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Lineweaver Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $766,347 - $856,895	-13,238 Reduced 39.47%	20,303 $1.18 Million
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $13,570 - $15,067	-213 Reduced 0.63%	33,541 $2.14 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $124,126 - $140,787	1,889 Added 5.93%	33,754 $2.34 Million
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $2.18 Million - $2.58 Million	31,865 New	31,865 $0
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $243,104 - $283,403	-4,533 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$59.17 - $69.31 $47,276 - $55,378	799 Added 21.4%	4,533 $268,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $231,171 - $251,746	3,734 New	3,734 $249,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.